Javascript must be enabled to continue!
Matrix metalloproteinase-8 inhibitors mitigate sepsis-induced myocardial injury in rats
View through CrossRef
BackgroundSepsis-induced myocardial injury (SIMI) is caused by a variety of mechanisms. The aim of the study is to investigate the effects of metalloproteinase-8 (MMP-8) on SIMI and its mechanisms in rats.MethodsForty male Sprague Dawley rats were randomly divided into four groups: MMP-8 inhibitor (M8I), dexamethasone (DEX), sepsis, and sham groups. The sepsis model was established by cecal ligation and puncture (CLP). Rats in the M8I group immediately received an intraperitoneal injection of M8I (0.1 mg/kg) after CLP. Rats in the DEX group immediately received an intraperitoneal (IP) injection of DEX (2 mg/kg). Rats in the sepsis and sham groups received intraperitoneal injections of normal saline. Rats were sacrificed 12 hours after CLP. Paraffin sections were stained with hematoxylin and eosin to observe the myocardium. The myocardial ultrastructure was observed with transmission electron microscopy. MMP-8, tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) were detected by immunohistochemistry. The expression of MMP-8 was measured by Western blotting. TNF-α and IL-1β levels in serum and myocardial tissue were determined by enzyme-linked immunosorbent assay.ResultsCompared with the sham group, the myocardium in the sepsis group was seriously injured. MMP-8, TNF-α and IL-1β expression was higher in the sepsis group than in the sham group. Treatment with M8I or DEX, however, attenuated sepsis induced histopathological changes in the heart, and was associated with significant reductions in serum and myocardial levels of TNF-α and IL-1β (P<0.05). M8I significantly inhibited MMP-8 expression in myocardial tissue (P<0.05). In addition, treatment with DEX was not associated with a change in myocardial levels of MMP-8 (P>0.05).ConclusionMMP-8 inhibitor attenuated myocardial injury in septic rats, which might be related to reduced expression of TNF-α and IL-1β.
Ovid Technologies (Wolters Kluwer Health)
Title: Matrix metalloproteinase-8 inhibitors mitigate sepsis-induced myocardial injury in rats
Description:
BackgroundSepsis-induced myocardial injury (SIMI) is caused by a variety of mechanisms.
The aim of the study is to investigate the effects of metalloproteinase-8 (MMP-8) on SIMI and its mechanisms in rats.
MethodsForty male Sprague Dawley rats were randomly divided into four groups: MMP-8 inhibitor (M8I), dexamethasone (DEX), sepsis, and sham groups.
The sepsis model was established by cecal ligation and puncture (CLP).
Rats in the M8I group immediately received an intraperitoneal injection of M8I (0.
1 mg/kg) after CLP.
Rats in the DEX group immediately received an intraperitoneal (IP) injection of DEX (2 mg/kg).
Rats in the sepsis and sham groups received intraperitoneal injections of normal saline.
Rats were sacrificed 12 hours after CLP.
Paraffin sections were stained with hematoxylin and eosin to observe the myocardium.
The myocardial ultrastructure was observed with transmission electron microscopy.
MMP-8, tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) were detected by immunohistochemistry.
The expression of MMP-8 was measured by Western blotting.
TNF-α and IL-1β levels in serum and myocardial tissue were determined by enzyme-linked immunosorbent assay.
ResultsCompared with the sham group, the myocardium in the sepsis group was seriously injured.
MMP-8, TNF-α and IL-1β expression was higher in the sepsis group than in the sham group.
Treatment with M8I or DEX, however, attenuated sepsis induced histopathological changes in the heart, and was associated with significant reductions in serum and myocardial levels of TNF-α and IL-1β (P<0.
05).
M8I significantly inhibited MMP-8 expression in myocardial tissue (P<0.
05).
In addition, treatment with DEX was not associated with a change in myocardial levels of MMP-8 (P>0.
05).
ConclusionMMP-8 inhibitor attenuated myocardial injury in septic rats, which might be related to reduced expression of TNF-α and IL-1β.
Related Results
To Determine The Association Of Serum Neopterin Levels In Sepsis
To Determine The Association Of Serum Neopterin Levels In Sepsis
Abstract
ABSTRACT
Background: Sepsis is a leading cause of death worldwide. Sepsis results in state of multiorgan dysfunction in the body. Early identification and appropri...
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
Sepsis-Related Mortality Rates and Trends Based on Site of Infection
OBJECTIVES:
Sepsis is defined as life-threatening organ dysfunction triggered by an underlying infection. A recent study noted that the overall sepsis-related mortality...
Septic Shock and Myocardial Dysfunction
Septic Shock and Myocardial Dysfunction
Cardiac dysfunction in sepsis is strongly linked to increased mortality. The pathophysiology of sepsis-induced Myocardial dysfunction is multifaceted, involving impaired myocardial...
Autoantibodies against β3-adrenoceptor reduce the susceptibility to myocardial ischemic/reperfusion injury of heart failure rats
Autoantibodies against β3-adrenoceptor reduce the susceptibility to myocardial ischemic/reperfusion injury of heart failure rats
Objective
Choosing chronic heart failure rats as starting point, to observe whether Autoantibodies against β3-adrenoceptor (β3AA) can reduce the susceptibility to...
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Objectives: Anterior cruciate ligament (ACL) reconstruction is the 6th most common orthopedic procedure performed in the United States (1,2). There is substantial evidence to sugge...
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Therapeutic potential of SGLT-2 inhibitors and DDP4 inhibitors in elderly patients with type 2 diabetes mellitus and benign prostatic hyperplasia
Background. Benign prostatic hyperplasia (BPH) has recently been linked to diabetes mellitus and insulin resistance. This study aims to explore whether the use of either sodium-glu...
Infusion therapy for sepsis in patients with burns
Infusion therapy for sepsis in patients with burns
Background. Sepsis develops in 8-42.5 % of patients with burns and is the leading cause of death among them. The criteria for sepsis are suspected or documented infection and the p...
Societal costs of sepsis in the Netherlands
Societal costs of sepsis in the Netherlands
Abstract
Background
Sepsis is a life-threatening syndrome characterized by acute loss of organ function due to infection. Sepsis survivors are at ri...

